[1] MA L Z, ZHANG Y R, LI Y Z, et al. Cataract, cataract surgery, and risk of incident dementia: a prospective cohort study of 300, 823 participants[J]. Biol Psychiatry, 2023, 93(9): 810-819. [2] PELLEGRINI M, BERNABEI F, SCHIAVI C, et al. Impact of cataract surgery on depression and cognitive function: systematic review and meta-analysis[J]. Clin Exp Ophthalmol, 2020, 48(5): 593-601. [3] EVERED L, SILBERT B, KNOPMAN D S, et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery: 2018[J]. Br J Anaesth, 2018, 121(5): 1005-1012. [4] HUET O, GARGADENNEC T, OILLEAU J F, et al. Prevention of post-operative delirium using an overnight infusion of dexmedetomidine in patients undergoing cardiac surgery: a pragmatic, randomized, double-blind, placebo-controlled trial[J]. Crit Care, 2024, 28(1): 64. [5] LIAO Y Q, MIN J, WU Z X, et al. Comparison of the effects of remimazolam and dexmedetomidine on early postoperative cognitive function in elderly patients with gastric cancer[J]. Front Aging Neurosci, 2023, 15: 1123089. [6] LEE C S, GIBBONS L E, LEE A Y, et al. Association between cataract extraction and development of dementia[J]. JAMA Intern Med,2022,182(2): 134-141. [7] WANG J, XIN Y, CHU T, et al. Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-κB signaling pathway[J]. Biomed Pharmacother, 2022, 150: 113006. [8] CHANG C Y, CHEN H A, CHIEN Y J, et al. Attenuation of the increase in intraocular pressure with dexmedetomidine: systematic review with meta-analysis and trial sequential analysis[J]. J Clin Anesth, 2021: 110065. doi: 10.1016/j.jclinane.2020.110065. [9] 宋一凡, 江林昊, 杨谦梓, 等. 右美托咪定的中枢神经作用机制研究进展[J]. 上海交通大学学报(医学版), 2024, 44(5): 626-634. [10] WANG S, YU X, CHENG L, et al. Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice[J]. Cell Death Dis, 2024, 15(6): 448. [11] KLASSEN S A, LIMBERG J K, HARVEY R E, et al. Central α(2)-adrenergic mechanisms regulate human sympathetic neuronal discharge strategies[J]. J Physiol,2024, 602(16): 4053-4071. [12] ZHOU W, ZHANG D, TIAN S, et al. Optimal dose of dexmedetomidine for perioperative blood glucose regulation in non-diabetic patients undergoing gastrointestinal malignant tumor resection: a randomized double-blinded controlled trial[J]. J Invest Surg, 2021, 34(8): 869-874. [13] ZHANG K, REN Y Q, XUE Y, et al. Alpha 2-adrenoceptor participates in anti-hyperalgesia by regulating metabolic demand[J]. Front Pharmacol, 2024, 15:1359319. [14] HUIKANG W, SHIYA C, DI P, et al. Elucidation of dexmedetomidine-induced analgesic tolerance mechanisms in neuropathic pain with modulation of SGK1, NR2A, and NR2B expression via the spinal SGK1/NF-κB signalling pathway[J]. J Cell Mol Med, 2025, 29(6):e70372. [15] ANUNCIBAY S B, MA Y, NOLLET M, et al. The locus coeruleus maintains core body temperature and protects against hypothermia during dexmedetomidine-induced sedation[J]. Proc Natl Acad Sci U S A, 2025, 122(41): e2422878122. [16] LIU X, LI Y, KANG L, et al. Recent advances in the clinical value and potential of dexmedetomidine[J]. J Inflamm Res, 2021, 14: 7507-7527. |